NEW YORK, NY / ACCESS Newswire / February 3, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn ...

The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...

DUBAI, UAE - Media OutReach Newswire - 28 January 2025 - AstraZeneca, a leading multinational pharmaceutical and ...

The firm scrapped its £450m investment despite the government's offer of support, the government says.

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune ...

Science minister Sir Chris Bryant said the Government feels regretful about the plan being ditched and ‘would prefer to have ...

AstraZeneca has retracted a planned £450 million investment in Britain, citing reduced government support as a key factor.

AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...

Sir Chris Bryant said the Government made a "significant offer" to AstraZeneca but still stopped short of the £90m offered by ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans, ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...